ZURA Latest News, Press Relases and Analysis

All

Press Releases

25 days ago - By: Zura Bio Limited

Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates

2 months ago - By: Benzinga - Mentions: NBY APDN GOVX FATE ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

a year ago - By: BusinessInsider

ZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024

a year ago - By: InvestorPlace

ZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024

2 months ago - By: Benzinga - Mentions: ENTA MRUS MLTX KALA ...

12 Health Care Stocks Moving In Monday's Intraday Session

4 months ago - By: Zura Bio Limited

Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference

4 months ago - By: Zura Bio Limited

Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

4 months ago - By: Stocktwits - Mentions: NVS

Novartis Drug Shows Improvement In Sjögren's Disease In Late-Stage Trials: Analyst Deems Data Positive For Zura Bio As Well

5 months ago - By: Zura Bio

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Zura Bio Limited

Zura Bio Announces Chief Financial Officer Transition

6 months ago - By: Zura Bio Limited

Zura Bio to Present at the Jefferies Global Healthcare Conference

7 months ago - By: Zura Bio Limited

Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa

7 months ago - By: Zura Bio Limited

Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates

9 months ago - By: Zura Bio Limited

Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates

10 months ago - By: Zura Bio Limited

Zura Bio to Present at the Leerink Partners Global Healthcare Conference

a year ago - By: Zura Bio Limited

Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis

a year ago - By: Zura Bio Limited

Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference

a year ago - By: Zura Bio Limited

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis

a year ago - By: Zura Bio Limited

Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

a year ago - By: Zura Bio

Zura Bio to Participate in Two Upcoming Investor Conferences in November

a year ago - By: Zura Bio Limited

Zura Bio to Present at Three Upcoming Investor Conferences in September

a year ago - By: Zura Bio Limited

Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

a year ago - By: Zura Bio Limited

Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants

a year ago - By: Zura Bio Limited

Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants

a year ago - By: Sagimet Biosciences Inc. - Mentions: SGMT BRNS TRVN RCUS ...

Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

a year ago - By: InvestorPlace - Mentions: VKTX ALT

3 Undervalued Biotech Stocks With Breakout Potential

a year ago - By: Zura Bio Limited

Zura Bio Commences Warrant Exchange Offer and Consent Solicitation

a year ago - By: InvestorPlace - Mentions: VKTX GPCR LLY

The 3 Most Undervalued Biotech Stocks to Buy in July 2024

1 years ago - By: Zura Bio Limited

Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024

2 years ago - By: Zura Bio Limited

Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology

2 years ago - By: Zura Bio Limited

Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024

2 years ago - By: Zura Bio Limited

ZURA BIO LTD (ZURA) Stock News

ZURA Latest News, Press Relases and Analysis

Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates

12 Health Care Stocks Moving In Tuesday's Intraday Session

ZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024

ZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024

12 Health Care Stocks Moving In Monday's Intraday Session

Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference

Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

Novartis Drug Shows Improvement In Sjögren's Disease In Late-Stage Trials: Analyst Deems Data Positive For Zura Bio As Well

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zura Bio Announces Chief Financial Officer Transition

Zura Bio to Present at the Jefferies Global Healthcare Conference

Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa

Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates

Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates

Zura Bio to Present at the Leerink Partners Global Healthcare Conference

Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis

Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis

Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

Zura Bio to Participate in Two Upcoming Investor Conferences in November

Zura Bio to Present at Three Upcoming Investor Conferences in September

Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants

Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants

Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

3 Undervalued Biotech Stocks With Breakout Potential

Zura Bio Commences Warrant Exchange Offer and Consent Solicitation

The 3 Most Undervalued Biotech Stocks to Buy in July 2024

Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024

Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology

Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024

Zura Bio Announces Participation in June Investor Conferences